E
Moderna, Inc. MRNA
$30.49 $0.210.69% NASDAQ
Recommendation
Prev Close
$27.59
Volume
6,972,646
Avg Vol (90D)
10,645,664
Market Cap
$10.67B
Dividend & Yield
--
52-Week Range
$23.15 - $129.39
P/E (TTM)
--
EPS (TTM)
-$8.74
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Moderna Stock Looks Ripe for a Short Squeeze
5/22/2025 - MarketBeat
Moderna Says mRNA Flu Vaccine Sailed Through Trial, Beating Standard Shot
7/4/2025 - Slashdot
Why Moderna Stock Was So Healthy This Week
7/4/2025 - Fool.com Headlines
Top Biotech Stocks To Add to Your Watchlist - July 4th
7/4/2025 - MarketBeat
Biotech Stocks To Keep An Eye On - July 3rd
7/3/2025 - MarketBeat
Moderna (NasdaqGS:MRNA) Joins Russell Midcap Indices In Late June 2025
7/3/2025 - Simply Wall St
Mixed options sentiment in Moderna with shares up 0.58%
7/3/2025 - The Fly
MRNA Stock Jumps on CDC's Revised RSV Vaccine Recommendations
7/3/2025 - Zacks Investment Research
The 16 Investments I Made With My $1.8m Inheritance
7/3/2025 - 24/7 Wall St.
RFK Jr.'s top FDA vaccine official restricts 2 COVID vaccine approvals against advice of agency scientists
7/3/2025 - Fortune
Moderna (MRNA, $30.28) RSI Indicator left the overbought zone on July 02, 2025
7/3/2025 - Tickeron - Stocks
CDC Greenlights Vaccines From Pfizer, Moderna, GSK Amid Shakeup Of Advisory Panel
7/3/2025 - Stocktwits News Feed
FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff
7/2/2025 - The Mercury News: Health
Moderna To Ask For Clearance For Combination COVID-Influenza Vaccine
7/2/2025 - Zero Hedge
FDA Limits Broader Use of Moderna (MRNA) Vaccine
7/2/2025 - GuruFocus
Biotech Stocks To Follow Today - July 2nd
7/2/2025 - MarketBeat
Investors Purchase Large Volume of Call Options on Moderna (NASDAQ:MRNA)
7/2/2025 - MarketBeat
Top 10 Healthcare AI Stocks to Buy According to Hedge Funds
7/2/2025 - Insider Monkey
Moderna (MRNA, $28.69) price may drop as it broke higher Bollinger Band on Jul 01, 2025
7/2/2025 - Tickeron - Stocks
Moderna says mRNA flu vaccine sailed through trial, beating standard shot
7/1/2025 - Ars Technica
Moderna Stock Gains on Encouraging Flu Vaccine Data
7/1/2025 - Zacks Investment Research
Flagship Pioneering Unveils Terrana Biosciences to Deliver Adaptive, Targeted Agricultural Solutions through a Novel RNA Technology Platform
7/1/2025 - PR Newswire
Company News for Jul 1, 2025
7/1/2025 - Zacks Investment Research
13,644 Shares in Moderna, Inc. (NASDAQ:MRNA) Acquired by Diversified Trust Co
7/1/2025 - MarketBeat
MarketBeat Week in Review – 03/10 - 03/14
3/15/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$3.18B
EBITDA (TTM)
-$3.54B
EBIT (TTM)
-$3.73B
Net Income (TTM)
-$3.36B
Balance Sheet
Total Assets (Q)
$12.70B
Total Debt (Q)
$745.00M
Total Liabilities (Q)
$2.64B
Book Value Per Share (Q)
$26.01
Cash Flow
Cash from Operations (TTM)
-$3.05B
Cash from Investing (TTM)
$2.56B
Cash from Financing (TTM)
$46.00M
Net Change in Cash (TTM)
-$445.00M
Filings
Filing Date
Thursday, May 1, 2025
Period Date
Monday, March 31, 2025
Next Filing
Beginning of August (est)
Price History
Loading...
Beta
0.54
7-Day Total Return
17.72%
30-Day Total Return
22.65%
60-Day Total Return
18.50%
90-Day Total Return
-9.61%
Year to Date Total Return
-27.40%
1-Year Total Return
-73.70%
2-Year Total Return
-74.95%
3-Year Total Return
-79.67%
5-Year Total Return
-50.50%
52-week Low
Apr 07, 2025 - $23.15
52-week High
Jul 12, 2024 - $129.39
Valuation
Market Cap
$10.67B - Large Cap
Enterprise Value
$3.02B
Price/Sales (TTM)
3.35
Price/Book (Q)
1.06
Dividends and Shares
Shares Outstanding
386.00M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.modernatx.com
Phone Number
617 714 6500
Address
325 Binney Street
Cambridge, MA 02142
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID... more
NASDAQ 07/03/2025 1:00PM Eastern Quotes delayed